Pancreatic Cancer Research

ResearcherChinese Academy of SciencesActive in the last 2 years

Jie Tian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0498-0432; OpenAlex author ID A5100429270. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
41
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 4 papers · 2020: 1 paper · 2021: none · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper

Papers 13

  1. Magnetic-optical dual-modality imaging monitoring chemotherapy efficacy of pancreatic ductal adenocarcinoma with a low-dose fibronectin-targeting Gd-based cont… Co-author DOI 10.1007/s00259-024-06617-w↗
  2. An ultra-small bispecific protein augments tumor penetration and treatment for pancreatic cancer. Co-author DOI 10.1007/s00259-023-06115-5↗
  3. Deep learning radiomics of dual-energy computed tomography for predicting lymph node metastases of pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00259-021-05573-z↗
  4. Optical magnetic multimodality imaging of plectin-1-targeted imaging agent for the precise detection of orthotopic pancreatic ductal adenocarcinoma in mice. Co-author DOI 10.1016/j.ebiom.2022.104040↗
  5. Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis. Co-author DOI 10.1186/s12916-022-02258-8↗
  6. Construction of a novel bispecific fusion protein to enhance targeting for pancreatic cancer imaging. Co-author DOI 10.1016/j.biomaterials.2020.120161↗
  7. An Innovation for Treating Orthotopic Pancreatic Cancer by Preoperative Screening and Imaging-Guided Surgery. Last author DOI 10.1007/s11307-018-1209-8↗
  8. Targeting carbon nanotubes based on IGF-1R for photothermal therapy of orthotopic pancreatic cancer guided by optical imaging. Last author DOI 10.1016/j.biomaterials.2018.12.025↗
  9. Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics. Co-author DOI 10.1016/j.ejrad.2019.05.024↗
  10. Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer. Co-author DOI 10.3389/fonc.2019.00973↗
  11. A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer. Last author DOI 10.1016/j.biomaterials.2018.08.048↗
  12. Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation. Co-author DOI 10.1371/journal.pone.0193318↗
  13. A Comparative Study of Clinical Intervention and Interventional Photothermal Therapy for Pancreatic Cancer. Last author DOI 10.1002/adma.201700448↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kun Wang · 6 shared papers, 2018–2023 · strength 0.74
  2. Zhengyu Jin · 3 shared papers, 2019–2024 · strength 0.47
  3. Wenjia Zhang · 2 shared papers, 2022–2024 · strength 0.37
  4. Xinming Zhao · 2 shared papers, 2020–2023 · strength 0.30
  5. Tong Tong · 2 shared papers, 2022 · strength 0.27
  6. Huadan Xue · 2 shared papers, 2019–2022 · strength 0.26
  7. Huadan Xue · 1 shared paper, 2024 · strength 0.21
  8. Qian Wang · 2 shared papers, 2018–2020 · strength 0.19
  9. Zihua Wang · 2 shared papers, 2018–2020 · strength 0.19
  10. Xiaoyuan Liang · 2 shared papers, 2019 · strength 0.19
  11. Ziyu Han · 2 shared papers, 2019 · strength 0.19
  12. Seok Hyun Yun · 1 shared paper, 2023 · strength 0.18
  13. Qian Wang · 1 shared paper, 2023 · strength 0.18
  14. Xiaolong Liang · 1 shared paper, 2022 · strength 0.16
  15. Liang Zhu · 1 shared paper, 2022 · strength 0.16
  16. Jionghui Gu · 1 shared paper, 2022 · strength 0.14
  17. Tianan Jiang · 1 shared paper, 2022 · strength 0.14
  18. Ling Song · 1 shared paper, 2022 · strength 0.14
  19. Shuiqing Zhuo · 1 shared paper, 2022 · strength 0.13
  20. Chao An · 1 shared paper, 2022 · strength 0.13
  21. Lizhi Liu · 1 shared paper, 2022 · strength 0.13
  22. Dan Li · 1 shared paper, 2020 · strength 0.11
  23. Zheng Li · 1 shared paper, 2020 · strength 0.11
  24. Ji‐Xin Cheng · 1 shared paper, 2018 · strength 0.11
  25. Junjie Li · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.